PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $626,000 | +12.8% | 88,700 | 0.0% | 0.00% | – |
| Q4 2020 | $555,000 | +13.3% | 88,700 | -2.1% | 0.00% | – |
| Q3 2020 | $490,000 | +13.7% | 90,600 | +9.8% | 0.00% | – |
| Q2 2020 | $431,000 | +106.2% | 82,500 | +24.4% | 0.00% | – |
| Q1 2020 | $209,000 | -57.5% | 66,300 | -45.7% | 0.00% | – |
| Q4 2019 | $492,000 | -6.6% | 122,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $527,000 | +14.6% | 122,000 | +5.8% | 0.00% | 0.0% |
| Q2 2019 | $460,000 | -25.6% | 115,300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $618,000 | +4.6% | 115,300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $591,000 | -49.6% | 115,300 | -4.6% | 0.00% | -50.0% |
| Q3 2018 | $1,173,000 | -4.5% | 120,906 | +0.4% | 0.00% | 0.0% |
| Q2 2018 | $1,228,000 | -21.5% | 120,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,565,000 | – | 120,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |